Trypanosoma cruzi seroprevalence and associated risk factors in cancer patients from Southern Brazil
Rev. Soc. Bras. Med. Trop
;
49(6): 768-771, Dec. 2016. tab
Article
in English
| LILACS
| ID: biblio-1041389
ABSTRACT
Abstract INTRODUCTION:
The aim of this study was to investigate the prevalence of Chagas disease in patients treated at a Public Oncology Service in the City of Pelotas, Southern Brazil.METHODS:
This study included 200 individuals undergoing cancer treatment and involved the use of a questionnaire and venous blood collection for the detection of anti-Trypanosoma cruzi antibody.RESULTS:
The study found a 5% prevalence of patient seropositivity. Significant variables are presented and discussed in the article.CONCLUSIONS:
Serological T. cruzi checks are recommended in cancer patients, especially individuals from endemic areas in Brazil and other Latin American countries.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Trypanosoma cruzi
/
Antibodies, Protozoan
/
Chagas Disease
/
Neoplasms
Type of study:
Diagnostic study
/
Etiology study
/
Prevalence study
/
Risk factors
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
Country/Region as subject:
South America
/
Brazil
Language:
English
Journal:
Rev. Soc. Bras. Med. Trop
Journal subject:
Tropical Medicine
Year:
2016
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Federal de Pelotas/BR
Similar
MEDLINE
...
LILACS
LIS